Samjin Pharmaceutical Vice President Jo Gyu-hyeong Plans to Receive 135,000 Shares as Gift from Jo Ui-hwan, Ownership to Rise to 4.20%
Samjin Pharmaceutical's registered executive Vice President Jo Gyu-hyeong has filed a planned transaction report, disclosing his intention to receive a gift of 135,000 common shares from relative Jo Ui-hwan on August 10, 2026.
This gift is an individual transfer of shares with no capital changes or dilution for the company. Upon completion, Jo's total holdings will increase from 425,000 shares to 560,000 shares, raising his stake from 3.19% to 4.20%.
The transaction is a non-market gift, classified as a routine insider transfer that does not directly impact the company's fundamentals or shareholder value.
[AI Summary]This is a personal gift receipt plan by an executive, unrelated to the company's capital structure, dividends, or financial health. The transaction size is only 1.01% of outstanding shares and involves no market sale or fundraising, thus its impact on the stock price is minimal. It is not a material event for investors.
KOSPI Filing Information
Report On Transaction Plan Of Specific Securities By Executives And Major Shareholders